HRA Pharma Seeks FDA Approval For Over The Counter Birth Control

HRA Pharma submitted an application to the FDA for the first over-the-counter delivery handle pill in the U.S. The Paris-centered corporation announced its options to give daily delivery management supplements in the U.S. without having a prescription. The birth command tablet known as Opill was very first authorized in 1973. In 2014, HRA Pharma acquired the drug from Pfizer, but it’s at the moment not marketed in the U.S. In accordance to the organization, the Food and drug administration will come to a decision on the application up coming calendar year.

Frédérique Welgryn, chief strategic functions and innovation officer at HRA Pharma, introduced a statement:

“This historic software marks a groundbreaking moment in contraceptive access and reproductive fairness in the U.S. Additional than 60 decades back, prescription birth control pills in the U.S. empowered gals to prepare if and when they needed to get expecting. Transferring a risk-free and successful prescription start command pill to OTC will aid even extra gals and persons accessibility contraception without the need of going through needless boundaries.”